Abhijat Kitchlu, Verônica T. Costa E Silva, Shuchi Anand, Jaya Kala, Ala Abudayyeh, Lesley A. Inker, Mitchell H. Rosner, Sabine Karam, Prakash Gudsoorkar, Shruti Gupta, Sheldon Chen, Nattawat Klomjit, Nelson Leung, Tomaz Milanez, Shveta S. Motwani, Sheikh B. Khalid, Vinay Srinivasan, Rimda Wanchoo, Jan H. Beumer, Geoffrey Liu, Nizar M. Tannir, Ani Orchanian-Cheff, Yimin Geng, Sandra M. Herrmann
{"title":"Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies – Perspectives from the ASON","authors":"Abhijat Kitchlu, Verônica T. Costa E Silva, Shuchi Anand, Jaya Kala, Ala Abudayyeh, Lesley A. Inker, Mitchell H. Rosner, Sabine Karam, Prakash Gudsoorkar, Shruti Gupta, Sheldon Chen, Nattawat Klomjit, Nelson Leung, Tomaz Milanez, Shveta S. Motwani, Sheikh B. Khalid, Vinay Srinivasan, Rimda Wanchoo, Jan H. Beumer, Geoffrey Liu, Nizar M. Tannir, Ani Orchanian-Cheff, Yimin Geng, Sandra M. Herrmann","doi":"10.2215/cjn.0000000000000509","DOIUrl":"https://doi.org/10.2215/cjn.0000000000000509","url":null,"abstract":"An abstract is unavailable. This article is available as a PDF only.","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141304341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blanca Tarragón, Yonatan Peleg, Geetha Jagannathan, Miroslav Sekulic, Jae-Hyung Chang, David J Cohen, Russell J Crew, Geoffrey K Dube, Hilda E Fernandez, Syed Ali Husain, Sumit Mohan, Heather K Morris, Gerald Appel, Paresh Jadav, Dominick Santoriello, Satoru Kudose, M Barry Stokes, Ibrahim Batal, Andrew Bomback
{"title":"C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First Two Years Post-Transplantation.","authors":"Blanca Tarragón, Yonatan Peleg, Geetha Jagannathan, Miroslav Sekulic, Jae-Hyung Chang, David J Cohen, Russell J Crew, Geoffrey K Dube, Hilda E Fernandez, Syed Ali Husain, Sumit Mohan, Heather K Morris, Gerald Appel, Paresh Jadav, Dominick Santoriello, Satoru Kudose, M Barry Stokes, Ibrahim Batal, Andrew Bomback","doi":"10.2215/CJN.0000000000000474","DOIUrl":"10.2215/CJN.0000000000000474","url":null,"abstract":"<p><strong>Background: </strong>C3 glomerulopathy (C3G), which encompasses C3 glomerulonephritis (C3GN) and dense deposit disease (DDD), results from dysregulation of the alternative complement pathway. Data on disease recurrence after kidney transplantation is limited, and details on histologic features of recurrent C3G are scarce. We aimed to evaluate C3G recurrence in the allograft, with a focus on histologic presentation and progression.</p><p><strong>Methods: </strong>We retrospectively analyzed 18 patients with native kidney failure attributed to C3G (12 C3GN and six DDD) who received a kidney transplant from January 2016 to January 2023. Demographic, genetic, clinical, and histologic data were studied. The Nanostring 770 genes immune profiling panel was used for transcriptomic analysis. Disease recurrence was the primary outcome.</p><p><strong>Results: </strong>During a median (IQR) follow-up period of 37 (18, 56) months, C3G recurrence occurred in 16 (89%) of patients (11 with C3GN and five with DDD), at a median (IQR) of 33 (13, 141) days post-transplantation. Over a third (38%) of recurrent cases were detected in protocol biopsies, and only 31% of patients presented with >300 mg/g of proteinuria. Recurrence in index biopsies was mainly established through a combination of immunofluorescence and electron microscopy findings, while it showed only subtle histologic alterations and no characteristic transcriptomic signals. Over time, histologic chronicity indices increased, but all allografts were functioning at the end of follow-up. Patients with recurrence of C3GN and DDD showed overlapping immunofluorescence and electron microscopy findings and had similar recurrence rate and time to recurrence.</p><p><strong>Conclusions: </strong>The majority of patients with native kidney failure attributed to C3G developed disease recurrence very early after kidney transplantation, usually with minimal proteinuria, mild histologic alterations, and favorable short-term allograft survival. Immunofluorescence and electron microscopy played a crucial role in detecting early, sub-clinical recurrence of C3GN and DDD, which showed significant overlapping features.</p>","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141288898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Céline Monard, Nathan Bianchi, Tatiana Kelevina, Marco Altarelli, Aziz Chaouch, Antoine Schneider
{"title":"Averaged versus Persistent Reduction in Urine Output to Define Oliguria in Critically Ill Patients: An Observational Study.","authors":"Céline Monard, Nathan Bianchi, Tatiana Kelevina, Marco Altarelli, Aziz Chaouch, Antoine Schneider","doi":"10.2215/CJN.0000000000000493","DOIUrl":"10.2215/CJN.0000000000000493","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141285262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carla Nester, Dima A Decker, Matthias Meier, Shakil Aslam, Andrew S Bomback, Fernando Caravaca-Fontán, Terence H Cook, David L Feldman, Veronique Fremeaux-Bacchi, Daniel P Gale, Ann Gooch, Sally Johnson, Christoph Licht, Mohit Mathur, Matthew C Pickering, Manuel Praga, Giuseppe Remuzzi, Viknesh Selvarajah, Richard J Smith, Hossein Tabriziani, Nicole van de Kar, Yaqin Wang, Edwin Wong, Kirtida Mistry, Mark Lim, Cesia Portillo, Seyi Balogun, Howard Trachtman, Aliza Thompson
{"title":"Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group.","authors":"Carla Nester, Dima A Decker, Matthias Meier, Shakil Aslam, Andrew S Bomback, Fernando Caravaca-Fontán, Terence H Cook, David L Feldman, Veronique Fremeaux-Bacchi, Daniel P Gale, Ann Gooch, Sally Johnson, Christoph Licht, Mohit Mathur, Matthew C Pickering, Manuel Praga, Giuseppe Remuzzi, Viknesh Selvarajah, Richard J Smith, Hossein Tabriziani, Nicole van de Kar, Yaqin Wang, Edwin Wong, Kirtida Mistry, Mark Lim, Cesia Portillo, Seyi Balogun, Howard Trachtman, Aliza Thompson","doi":"10.2215/CJN.0000000000000505","DOIUrl":"10.2215/CJN.0000000000000505","url":null,"abstract":"<p><p>Randomized clinical trials are underway to evaluate the efficacy of novel agents targeting the alternative complement pathway in patients with C3 glomerulopathy (C3G), a rare glomerular disease. The Kidney Health Initiative convened a panel of experts in C3G to ( 1 ) assess the data supporting the use of the prespecified trial end points as measures of clinical benefit and ( 2 ) opine on efficacy findings they would consider compelling as treatment(s) of C3G in native kidneys. Two subpanels of the C3G Trial Endpoints Work Group reviewed the available evidence and uncertainties for the association between the three prespecified end points-( 1 ) proteinuria, ( 2 ) eGFR, and ( 3 ) histopathology-and anticipated outcomes. The full work group provided feedback on the summaries provided by the subpanels and on what potential treatment effects on the proposed end points they would consider compelling to support evidence of an investigational product's effectiveness for treating C3G. Members of the full work group agreed with the characterization of the data, evidence, and uncertainties, supporting the end points. Given the limitations of the available data, the work group was unable to define a minimum threshold for change in any of the end points that might be considered clinically meaningful. The work group concluded that a favorable treatment effect on all three end points would provide convincing evidence of efficacy in the setting of a therapy that targeted the complement pathway. A therapy might be considered effective in the absence of complete alignment in all three end points if there was meaningful lowering of proteinuria and stabilization or improvement in eGFR. The panel unanimously supported efforts to foster data sharing between academic and industry partners to address the gaps in the current knowledge identified by the review of the end points in the aforementioned trials.</p>","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ruqi Xu, Qi Gao, Yuping Zhang, Yuxin Lin, Yanqin Li, Licong Su, Shiyu Zhou, Yue Cao, Peiyan Gao, Pingping Li, Fan Luo, Ruixuan Chen, Xiaodong Zhang, Sheng Nie, Xin Xu
{"title":"Associations between Different Antivirals and Hospital-Acquired Acute Kidney Injury in Adults with Herpes Zoster.","authors":"Ruqi Xu, Qi Gao, Yuping Zhang, Yuxin Lin, Yanqin Li, Licong Su, Shiyu Zhou, Yue Cao, Peiyan Gao, Pingping Li, Fan Luo, Ruixuan Chen, Xiaodong Zhang, Sheng Nie, Xin Xu","doi":"10.2215/CJN.0000000000000452","DOIUrl":"10.2215/CJN.0000000000000452","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140289467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Quality Systems Perspective on Sensitization and Kidney Allocation System Changes.","authors":"Laurel Damashek","doi":"10.2215/CJN.0000000000000478","DOIUrl":"10.2215/CJN.0000000000000478","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168821/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140917408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Matthew C Breeggemann, Peter C Harris, John C Lieske, Gregory E Tasian, Kyle D Wood
{"title":"How We Treat Primary Hyperoxaluria Type 1.","authors":"Matthew C Breeggemann, Peter C Harris, John C Lieske, Gregory E Tasian, Kyle D Wood","doi":"10.2215/CJN.0000000000000460","DOIUrl":"10.2215/CJN.0000000000000460","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168812/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jesse D Schold, Anat R Tambur, Sumit Mohan, Bruce Kaplan
{"title":"Calibration of Priority Points for Sensitization Status of Kidney Transplant Candidates in the United States.","authors":"Jesse D Schold, Anat R Tambur, Sumit Mohan, Bruce Kaplan","doi":"10.2215/CJN.0000000000000449","DOIUrl":"10.2215/CJN.0000000000000449","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168827/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140177496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Benefit of Renin Angiotensin Aldosterone Blockade in Kidney Transplant Recipients: Is the Verdict in or Still to Be Answered?","authors":"Deirdre Sawinski, Amy K Mottl","doi":"10.2215/CJN.0000000000000479","DOIUrl":"10.2215/CJN.0000000000000479","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140959428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dana C Miskulin, Hocine Tighiouart, Caroline M Hsu, Daniel E Weiner
{"title":"Dialysate Sodium Lowering in Maintenance Hemodialysis: A Randomized Clinical Trial.","authors":"Dana C Miskulin, Hocine Tighiouart, Caroline M Hsu, Daniel E Weiner","doi":"10.2215/CJN.0000000000000431","DOIUrl":"10.2215/CJN.0000000000000431","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139730923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}